Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer

Sponsor
Yonsei University
Study ID
NCT00832689
Phase
PHASE2
Status
Completed

Conditions

  • Biliary Tract Cancer

Eligibility Criteria

Sex
ALL
Age
17 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The study hypothesis is that chemotherapy of irinotecan and gemcitabine will improve local control of cancer and prolong survival in patients with inoperable biliary tract cancer.

Key Dates

First listed
Jan 30, 2009
Start date
Jun 30, 2008
Status verified
Mar 2011
Primary completion
Feb 28, 2010
Completion
Mar 31, 2010

Study Design

Enrollment
39 participants (actual)
Primary purpose
TREATMENT

Arms

  • Experimental: 1

Related Studies